Acute intermittent porphyria presenting as a diffuse encephalopathy

Annals of Neurology

Volumn 57, Issue 4, 2005, Pages 581-584

  Maramattom, Boby V ^a   Zaldivar, Renzo A ^a   Glynn, Simon M ^a   Eggers, Scott D ^a   Wijdicks, Eelco F M ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMATIN;

ACUTE INTERMITTENT PORPHYRIA; ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DISEASE; CASE REPORT; CLINICAL FEATURE; DEMYELINATION; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; WHITE MATTER;

ADOLESCENT; BRAIN DISEASES; CARBOHYDRATES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMIN; HUMANS; MAGNETIC RESONANCE IMAGING; PORPHYRIA, ACUTE INTERMITTENT;

EID: 16344394580     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20432     Document Type: Article

References (13)

1. Aggarwal A, Quint DJ, Lynch JP 3rd. MR imaging of porphyric encephalopathy. AJR Am J Roentgenol 1994;162: 1218-1220.
2. Celik M, Forta H, Dalkilic T, Babacan G. MRI reveals reversible lesions resembling posterior reversible encephalopathy in porphyria. Neuroradiology 2002;44:839-841.
3. Garg RK. Acute intermittent porphyria: a cause of posterior leukoencephalopathy syndrome. J Assoc Physicians India 2000; 48:658.
4. King PH, Bragdon AC. MRI reveals multiple reversible cerebral lesions in an attack of acute intermittent porphyria. Neurology 1991;41:1300-1302.
5. Kupferschmidt H, Bont A, Schnorf H, et al. Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria. Ann Intern Med 1995;123: 598-600.
6. Utz N, Kinkel B, Hedde JP, Bewermeyer H. MR imaging of acute intermittent porphyria mimicking reversible posterior leukoencephalopathy syndrome. Neuroradiology 2001;43:1059-1062.
7. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002; 23:1038-1048.
8. Susa S, Daimon M, Morita Y, et al. Acute intermittent porphyria with central pontine myelinolysis and cortical laminar necrosis. Neuroradiology 1999;41:835-839.
9. Lai CW, Hung TP, Lin WS. Blindness of cerebral origin in acute intermittent porphyria. Report of a case and postmortem examination. Arch Neurol 1977;34:310-312.
10. Bylesjo I, Brekke OL, Prytz J, et al. Brain magnetic resonance imaging white-matter lesions and cerebrospinal fluid findings in patients with acute intermittent porphyria. Eur Neurol 2004; 51:1-5.
11. Bylesjo I, Forsgren L, Lithner F, Boman K. Epidemiology and clinical characteristics of seizures in patients with acute intermittent porphyria. Epilepsia 1996;37:230-235.
12. Bonkowsky HL, Sinclair PR, Emery S, Sinclair JF. Seizure management in acute hepatic porphyria: risks of valproate and clonazepam. Neurology 1980;30:588-592.
13. Meyer UA, Schuurmans MM, Lindberg RL. Acute porphyrias: pathogenesis of neurological manifestations. Semin Liver Dis 1998;18:43-52.